The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis.

Sci Rep · 2024 · PMC11128447 · PMID 38797735

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

There was a positive trend according to stage progression in serum TNC levels in control, stage 0–II, and stage III–IV pancreatic cancer patients (Fig. 3 b).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.